Pharmacist-Led Consultation for Viagra Connect

You can buy Viagra Connect online from Manual.

Electronic Supplementary Material

Descriptive statistics were used.Results: The final sample had 297 patients, who reported that pharmacists inquired about blood pressure and heart comorbidities (91.9%), relevant illnesses (87.9%), medications (86.5%), ED diagnosis (82.2%), and were advised to consult their doctor regarding ED (51.2%). Furthermore, 85.5% of patients were advised on how to take VC correctly, 82.2% on possible side effects for which they might have to discontinue taking VC and consult their doctor, 80.1% on being informed that ED could be caused by underlying conditions. About 65.0% reported that they had visited (19.2%) or planned to visit (45.8%) their doctor. A majority (68.7%) also indicated that they had received advice on lifestyle modifications to manage their ED-related health risks.Conclusion: This survey provided a reasonable confirmation of the effectiveness of the VC aRMMs program and assurance that ED patients, when requesting and purchasing VC in UK pharmacies, are assessed appropriately for suitability of VC and receive the appropriate advice from pharmacists.Plain Language Summary: A national additional risk minimization measures (aRMMs) program was implemented to train pharmacists for safe supply of non-prescription VC to erectile dysfunction (ED) patients in United Kingdom (UK).A cross-sectional, web-based survey enrolled ED patients who purchased at least 1 supply of VC in UK, using a structured self-administered questionnaire. Patients were assessed for the suitability of VC and received appropriate advice from pharmacists.The final sample had 297 patients, who reported that pharmacists inquired about blood pressure and heart comorbidities, relevant illnesses, medications, ED diagnosis, and were advised to consult their doctor regarding ED.

Participation inViagra Connect®training guide to pharmacists

Additionally, most of the patients had consulted or planned to consult their doctors, on how to take VC correctly, on possible side effects for which they might have to discontinue taking VC and consult their doctor, on being informed that ED could be caused by underlying conditions, and on lifestyle modifications. A majority also indicated that they had received advice on lifestyle modifications to manage their ED-related health risks.This survey provided a reasonable confirmation of the effectiveness of the VC aRMMs program and assurance that ED patients, when requesting and purchasing VC in UK pharmacies, are assessed appropriately for suitability of VC and receive the appropriate advice from pharmacists.Keywords: aRMM, erectile dysfunction, pharmacist, sildenafil citrate Erectile dysfunction (ED) is the inability to achieve or maintain an erection that is sufficient for satisfactory sexual performance.1 The overall prevalence of self-reported ED in men across aged 40–70 years has been estimated to be 45.2%.2 Organic (ie, neurogenic, endocrinological, vasculogenic, or drug-induced), psychogenic, or mixed causes may attribute to ED.3,4 ED may be a presenting symptom of undetected or underlying cardiovascular disease (CVD) in men.5 ED and CVD share several risk factors including advanced age, tobacco use, excessive alcohol consumption, diabetes mellitus, hyperlipidemia, obesity, depression among others.6,7 Additionally, ED is also known to cause substantial negative effects on the patient’s self-esteem, quality of life and emotional status.8,9 There are several treatment options recommended by European guidelines for ED management including intracavernosal injection, vacuum device, oral therapy with phosphodiesterase type 5 (PDE-5) inhibitors, topical/intra-urethral alprostadil along with lifestyle modification and patient education. Amongst all the treatment options, pharmacological treatment with oral PDE-5 inhibitors remain the main stay of treatment of ED.10 Sildenafil citrate is a potent and selective inhibitor of cyclic- guanosine monophosphate-specific phosphodiesterase enzyme which causes relaxation of smooth muscle in the corpus cavernosum.11 Eventually, sildenafil restores the natural erectile response to sexual stimulation and has been effectively used in the treatment of patient population with ED of varying etiologies and with diverse comorbidities.3,4,12 Sildenafil citrate (Viagra®), supplied via prescription, was approved in the European Union (EU) in 1998 for treatment of ED. A Decentralized Procedure (DCP) application for non-prescription (ie, behind the counter) 50 mg sildenafil (marketed as Viagra Connect® [VC] 50 mg film-coated tablets) was approved in the UK in November 2017 and became available in pharmacies in the UK in April 2018.13 This launch of VC in the UK, and its availability as a “behind the counter” (pharmacist-supervised) medicine augments the availability of pharmacists to help men to deal with both the physical and emotional impact of ED, and other wider potential health concerns associated with ED. To facilitate this, before and after launch of behind the counter VC, a pharmacist education program of additional risk minimization measures (aRMM, as defined by EMA [European Medicines Agency]), comprising a training guide and a checklist regarding the safe use of VC was implemented.

Patients’ Experience with Visiting or Planning to Visit Their Doctor

Using online resources, printed materials and in-store face-to-face sessions, pharmacists were trained to assess ED patients’ suitability of VC including an assessment of comorbidities and concomitant medications and to advise ED patients to consult their doctors within 6 months in order to assess any underlying health issues and the risk of misdiagnosis. This exploratory patient survey was conducted as part of the aRMM evaluation to assess patients’ experience while purchasing VC in a pharmacy without a prescription. This was achieved by knowing whether patients reported that they were assessed by a pharmacist for their suitability to receive VC and if they were advised by viagra black pharmacist to consult their doctor within 6 months of first supply. The survey also ascertained if patients reported having visited their doctor or planned to visit their doctor in the near future, being advised about the safe use of VC, potential causes of ED and lifestyle modifications by their pharmacist. This was a cross-sectional, web-based survey conducted in the UK between October 2020 and June 2021. Or, if you prefer the non-branded alternative, generic Sildenafil, we have that too. It’s just as effective, at a fraction of the price.

Undertreatment of Erectile Dysfunction: Claims Analysis of 6.2 Million Patients – medicines.org.uk – Viagra 25mg, 50mg, 100mg PROPS Irwin Goldstein, M.D., Tom F. Lue, M.D., Harin Padma-Nathan, M.D., Raymond C. Rosen, Ph.D., William D. Steers, M.D., and Pierre A. Wicker, M.D. Oral Sildenafil in the Treatment of Erectile Dysfunction – James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson (2007). Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction – Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction – reuters.com – Erectile dysfunction drugs vary in effectiveness, side effects – While we've ensured that everything you read on the Health Centre is medically reviewed and approved, information presented here is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

• Viagra Connect is an over-the-counter treatment for erectile dysfunction.
• It contains sildenafil, which improves blood flow to the penis.
• Available in pharmacies without a prescription.
• Patients should consult a pharmacist before use.
• Suitable for men aged 18 and over.
• Must be taken at least 30 minutes before activity.

It should never be relied upon for specific medical advice. If you have any questions or concerns, please talk to your doctor.

Sons Hair Loss Treatments

A pre-testing of survey questions was conducted in a sample of 29 patients prior to the implementation of the survey. This user-testing assessed the clarity of survey questions for interest and acceptance of the polls amongst the participants, as well as the flow and ease of completing the surveys. The findings and recommendations from the survey pre-testing were incorporated into the final version and tested in two pilot surveys for further refinement.8,14 This patient survey was administered online anonymously and expected to take approximately 5 minutes to complete by the participants. The survey was conducted in select Boots pharmacy stores, independent pharmacy stores and regional multiple pharmacies. Pharmacies were invited to participate in the study based on their monthly VC sales data during the months of March, April, and May 2020.

Supplementary Information

Also, Pharmacies throughout the UK selected, to maximize patient representativeness. All those patients who purchased VC from the participating pharmacies, received an invitation to partake in the survey. Pharmacists distributed survey invitation leaflets to all the patients during the survey period, according to a standard script.

Assessment by Pharmacist for Patient Suitability for VC

Back to Journals » Patient Preference and Adherence » Volume 18 Authors Li JZ , Lem JA, Younus M, Donde SS, Collins J, Zou KH Editor who approved publication: Dr Johnny Chen Jim Z Li,1 Joanna Asia Lem,2 Muhammad Younus,2 Shaantanu S Donde,3 Janine Collins,4 Kelly H Zou1 1Global Medical Analytics, Real-World Evidence, and Health Economics & Outcomes Research Viatris Inc., Canonsburg, PA, USA; 2Safety Surveillance Research, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA; 3Medical Affairs - Developed Markets, Viatris Inc., Dorking, UK; 4Safety, Epidemiology, Registries and Risk Management Department, UBC, Geneve, SwitzerlandCorrespondence: Kelly H Zou, Global Medical Analytics, Real-World Evidence, and Health Economics & Outcomes Research, Viatris Inc., Canonsburg, PA, USA, Tel +1.212-722-0087, Email [email protected]Purpose: A national additional risk minimization measures (aRMMs) program was implemented to train pharmacists for safe supply of non-prescription Viagra Connect® (VC) to erectile dysfunction (ED) patients in United Kingdom (UK). A survey aimed to evaluate the effectiveness of aRMMs.Methods: A cross-sectional, web-based survey enrolled ED patients who purchased at least 1 supply of VC in UK, using a structured self-administered questionnaire. Patients were assessed for the suitability of cheap viagra with dapoxetine VC and received appropriate advice from pharmacists.

Descriptive statistics were used.Results: The final sample had 297 patients, who reported that pharmacists inquired about blood pressure and heart comorbidities (91.9%), relevant illnesses (87.9%), medications (86.5%), ED diagnosis (82.2%), and were advised to consult their doctor regarding ED (51.2%). Furthermore, 85.5% of patients were advised on how to take VC correctly, 82.2% on possible side effects for which they might have to discontinue taking VC and consult their doctor, 80.1% on being informed that ED could be caused by underlying conditions. About 65.0% reported that they had visited (19.2%) or planned to visit (45.8%) their doctor. A majority (68.7%) also indicated that they had received advice on lifestyle modifications to manage their ED-related health risks.Conclusion: This survey provided a reasonable confirmation of the effectiveness of the VC aRMMs program and assurance that ED patients, when requesting and purchasing VC in UK pharmacies, are assessed appropriately for suitability of VC and receive the appropriate advice from pharmacists.Plain Language Summary: A national additional risk minimization measures (aRMMs) program was implemented to train pharmacists for safe supply of non-prescription VC to erectile dysfunction (ED) patients in United Kingdom (UK).A cross-sectional, web-based survey enrolled ED patients who purchased at least 1 supply of VC in UK, using a structured self-administered questionnaire. Patients were assessed for the suitability of VC and received appropriate advice from pharmacists.The final sample had 297 patients, who reported that pharmacists inquired about blood pressure and heart comorbidities, relevant illnesses, medications, ED diagnosis, and were advised to consult their doctor regarding ED.

Additionally, most of the patients had consulted or planned to consult their doctors, on how to take VC correctly, on possible side effects for which they might have to discontinue taking VC and consult their doctor, on being informed that ED could be caused by underlying conditions, and on lifestyle modifications. A majority also indicated that they had received advice on lifestyle modifications to manage their ED-related health risks.This survey provided a reasonable confirmation of the effectiveness of the VC aRMMs program and assurance that ED patients, when requesting and purchasing VC in UK pharmacies, are assessed appropriately for suitability of VC and receive the appropriate advice from pharmacists.Keywords: aRMM, erectile dysfunction, pharmacist, sildenafil citrate Erectile dysfunction (ED) is the inability to achieve or maintain an erection that is sufficient for satisfactory sexual performance.1 The overall prevalence of self-reported ED in men across aged 40–70 years has been estimated to be 45.2%.2 Organic (ie, neurogenic, endocrinological, vasculogenic, or drug-induced), psychogenic, or mixed causes may attribute to ED.3,4 ED may be a presenting symptom of undetected or underlying cardiovascular disease (CVD) in men.5 ED and CVD share several risk factors including advanced age, tobacco use, excessive alcohol consumption, diabetes mellitus, hyperlipidemia, obesity, depression among others.6,7 Additionally, ED is also known to cause substantial negative effects on the patient’s self-esteem, quality of life and emotional status.8,9 There are several treatment options recommended by European guidelines for ED management including intracavernosal injection, vacuum device, oral therapy with phosphodiesterase type 5 (PDE-5) inhibitors, topical/intra-urethral alprostadil along with lifestyle modification and patient education.

Cialis Together 10mg - 8 Tablets

You can buy Viagra Connect online from Manual. Or, if you prefer the non-branded alternative, generic Sildenafil, we have that too. It’s just as effective, at a fraction of the price. Undertreatment of Erectile Dysfunction: Claims Analysis of 6.2 Million Patients – medicines.org.uk – Viagra 25mg, 50mg, 100mg PROPS Irwin Goldstein, M.D., Tom F. Lue, M.D., Harin Padma-Nathan, M.D., Raymond C.

Study design

Rosen, Ph.D., William D. Steers, M.D., and Pierre A. Wicker, M.D. Oral Sildenafil in the Treatment of Erectile Dysfunction – James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson (2007). Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction – Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction – reuters.com – Erectile dysfunction drugs vary in effectiveness, side effects – While we've ensured that everything you read on the Health Centre is medically reviewed and approved, information presented here is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Tadalafil (Cialis)

It should never be relied upon for specific medical advice. If you have any questions or concerns, please talk to your doctor. Back to Journals » Patient Preference and Adherence » Volume 18 Authors Li JZ , Lem JA, Younus M, Donde SS, Collins J, Zou KH Editor who approved publication: Dr Johnny Chen Jim Z Li,1 Joanna Asia Lem,2 Muhammad Younus,2 Shaantanu S Donde,3 Janine Collins,4 Kelly H Zou1 1Global Medical Analytics, Real-World Evidence, and Health Economics & Outcomes Research Viatris Inc., Canonsburg, PA, USA; 2Safety Surveillance Research, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA; 3Medical Affairs - Developed Markets, Viatris Inc., Dorking, UK; 4Safety, Epidemiology, Registries and Risk Management Department, UBC, Geneve, SwitzerlandCorrespondence: Kelly H Zou, Global Medical Analytics, Real-World Evidence, and Health Economics & Outcomes Research, Viatris Inc., Canonsburg, PA, USA, Tel +1.212-722-0087, Email [email protected]Purpose: A national additional risk minimization measures (aRMMs) program was implemented to train pharmacists for safe supply of non-prescription Viagra Connect® (VC) to erectile dysfunction (ED) patients in United Kingdom (UK). A survey aimed to evaluate the effectiveness of aRMMs.Methods: A cross-sectional, web-based survey enrolled ED patients who purchased at least 1 supply of VC in UK, using a structured self-administered questionnaire. Patients were assessed for the suitability of cheap viagra with dapoxetine VC and received appropriate advice from pharmacists. Amongst all the treatment options, pharmacological treatment with oral PDE-5 inhibitors remain the main stay of treatment of ED.10 Sildenafil citrate is a potent and selective inhibitor of cyclic- guanosine monophosphate-specific phosphodiesterase enzyme which causes relaxation of smooth muscle in the corpus cavernosum.11 Eventually, sildenafil restores the natural erectile response to sexual stimulation and has been effectively used in the treatment of patient population with ED of varying etiologies and with diverse comorbidities.3,4,12 Sildenafil citrate (Viagra®), supplied via prescription, was approved in the European Union (EU) in 1998 for treatment of ED. A Decentralized Procedure (DCP) application for non-prescription (ie, behind the counter) 50 mg sildenafil (marketed as Viagra Connect® [VC] 50 mg film-coated tablets) was approved in the UK in November 2017 and became available in pharmacies in the UK in April 2018.13 This launch of VC in the UK, and its availability as a “behind the counter” (pharmacist-supervised) medicine augments the availability of pharmacists to help men to deal with both the physical and emotional impact of ED, and other wider potential health concerns associated with ED.

How it works

To facilitate this, before and after launch of behind the counter VC, a pharmacist education program of additional risk minimization measures (aRMM, as defined by EMA [European Medicines Agency]), comprising a training guide and a checklist regarding the safe use of VC was implemented. Using online resources, printed materials and in-store face-to-face sessions, pharmacists were trained to assess ED patients’ suitability of VC including an assessment of comorbidities and concomitant medications and to advise ED patients to consult their doctors within 6 months in order to assess any underlying health issues and the risk of misdiagnosis. This exploratory patient survey was conducted as part of the aRMM evaluation to assess patients’ experience while purchasing VC in a pharmacy without a prescription. This was achieved by knowing whether patients reported that they were assessed by a pharmacist for their suitability to receive VC and if they were advised by viagra black pharmacist to consult their doctor within 6 months of first supply. The survey also ascertained if patients reported having visited their doctor or planned to visit their doctor in the near future, being advised about the safe use of VC, potential causes of ED and lifestyle modifications by their pharmacist.

Avarante 10mg - 2 Tablets

Survey sample

Warnings and Precautions

This was a cross-sectional, web-based survey conducted in the UK between October 2020 and June 2021.

• Viagra Connect requires a brief health assessment at purchase.
• Patients should disclose any health issues or medications.
• Alcohol consumption may reduce effectiveness.
• It does not cause an instant erection; arousal needed.
• Side effects are usually mild and temporary.
• Seek medical advice if experiencing persistent problems.

A pre-testing of survey questions was conducted in a sample of 29 patients prior to the implementation of the survey. This user-testing assessed the clarity of survey questions for interest and acceptance of the polls amongst the participants, as well as the flow and ease of completing the surveys.

The findings and recommendations from the survey pre-testing were incorporated into the final version and tested in two pilot surveys for further refinement.8,14 This patient survey was administered online anonymously and expected to take approximately 5 minutes to complete by the participants. The survey was conducted in select Boots pharmacy stores, independent pharmacy stores and regional multiple pharmacies. Pharmacies were invited to participate in the study based on their monthly VC sales data during the months of March, April, and May 2020. Also, Pharmacies throughout the UK selected, to maximize patient representativeness. All those patients who purchased VC from the participating pharmacies, received an invitation to partake in the survey. Pharmacists distributed survey invitation leaflets to all the patients during the survey period, according to a standard script.